三個皮匠報告
政策庫
new
付費
搜索

印度制藥企業盈利預測與估值情況（Bloomberg一致預期）-行業數據

印度制藥企業盈利預測與估值情況（Bloomberg一致預期）
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）
我們按是否有制劑業務，把 30 家印度制藥企業分為兩類：API 制劑一體化型藥企、專注于原料藥型 API-focused。這兩類公司在發展過程中選擇了不同的路徑，資本市場表現有較大差異，但同類公司市值走勢具有較高相似性。
行業數據 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?88KB 圖片尺寸：2350*1450
同報告圖片
 / 32
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第1頁
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
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第2頁
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
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第3頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第4頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第5頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第6頁
fCBGWSB8IOWItuWJguS4gOS9k+WMliBQaGFybWHokKXkuJrmlLblhaXvvIhScy5ibu+8iSB8CnwgOi0tOiB8IDotLTogfAp8IEZZMDAgfCAxMDAgfAp8IEZZMDEgfCAxMjAgfAp8IEZZMDIgfCAxNTAgfAp8IEZZMDMgfCAxODAgfAp8IEZZMDQgfCAyMjAgfAp8IEZZMDUgfCAyNTAgfAp8IEZZMDYgfCAzMDAgfAp8IEZZMDcgfCAzNTAgfAp8IEZZMDggfCA0MDAgfAp8IEZZMDkgfCA0NTAgfAp8IEZZMTAgfCA1MDAgfAp8IEZZMTEgfCA1NTAgfAp8IEZZMTIgfCA2MDAgfAp8IEZZMTMgfCA3MDAgfAp8IEZZMTQgfCA4MDAgfAp8IEZZMTUgfCA5MDAgfAp8IEZZMTYgfCAxMDAwIHwKfCBGWTE3IHwgMTEwMCB8CnwgRlkxOCB8IDEyMDAgfAp8IEZZMTkgfCAxMzAwIHwKfCBGWTIwIHwgMTQwMCB8CnwgRlkyMSB8IDE1MDAgfAp8IEZZMjIgfCAxNjAwIHwKfCBGWTIzIHwgMTcwMCB8CnwgRlkyNCB8IDE4MDAgfAoK6LWE5paZ5p2l5rqQ77yaQ2FwaXRhbCBJUeOAgeaLm+WVhuivgeWIuA==
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第7頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第8頁
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
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第9頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第10頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第11頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第12頁
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
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第13頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第14頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第15頁
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
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第16頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第17頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第18頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第19頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第20頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第21頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第22頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第23頁
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
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第24頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第25頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第26頁
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
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第27頁
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
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第28頁
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第29頁
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
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第30頁
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
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第31頁
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
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第32頁
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
印度制藥企業盈利預測與估值情況（Bloomberg一致預期）_第33頁
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
所屬報告： 印度制藥系列研究（一）：知印鑒中30家印度藥企深度復盤啟示及中國原料藥產業發展路徑探討-241218（25頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站